Join Fox News for access to this content Plus special access to select articles and other premium content with your account – free of charge. Please enter a valid email address. By entering your email and pushing continue, you are agreeing to
A polio survivor, known as “Polio Paul”, has died after living for more than 70 years with the help of an iron lung. Paul Alexander earned his nickname “the man in the iron lung” after being left paralysed by polio when he
With hospitals in China reportedly overwhelmed by a surge of mysterious childhood pneumonia cases — and as outbreaks begin to crop up in areas of the U.S. — experts are weighing in on possible causes and recommendations. Dr. Sarah Park, medical director
AI model could help predict lung cancer risks in non-smokers, study finds: ‘Significant advancement’
Among the latest artificial intelligence innovations in health care, a routine chest X-ray could help identify non-smokers who are at a high risk for lung cancer. The study findings will be presented this week at the annual meeting of the Radiological Society
Pope Francis is receiving antibiotics to treat lung inflammation, the Vatican said Monday. The health update came after the pontiff canceled his weekly window appointment to greet people in St. Peter’s Square, sparking concerns for the pope, whose 87th birthday is next
Many lung cancer patients now have access to a potentially life-saving medication. Osimertinib, sold under the brand name Tagrisso, is available to patients with Stage 1B-3A lung cancer who have a certain genetic mutation and have had surgery to remove cancerous tumors.
A resident at the Methodist Village Senior Living facility in Fort Smith, Arkansas, has been diagnosed with Legionnaires’ disease. The Arkansas Health Care Association (AHCA) announced confirmation of the news last week. “We have one resident with a confirmed case of Legionnaires’,”
The American Cancer Society (ACS) has announced new guidelines for lung cancer screenings. Published in the ACS journal “CA: A Cancer Journal for Clinicians” on Wednesday, the advisory reconsiders those who are at high risk for developing lung cancer and which individuals
AstraZeneca said on Friday its and Daiichi Sankyo’s cancer drug Enhertu was recommended by the European Medicines Agency’s human medicines committee as a monotherapy to treat patients with a type of non-small cell lung cancer (NSCLC). The recommendation is based on the
Bacteria-containing dust found at day care centers could put children at a higher risk of asthma, a new study from the European Respiratory Society suggests. In the study, the researchers collected dust samples from 103 different day care facilities in Paris, France.